Selank is a synthetic heptapeptide consisting of the tetrapeptide tuftsin sequence extended at the C-terminus by a proline-glycine-proline motif. It is supplied here as a lyophilised powder in a sealed vial.
This listing is for the compound as an analytical and research material. No application, effect or property in humans or animals is stated or implied.
Background
Tuftsin is a naturally occurring tetrapeptide derived from the heavy chain of immunoglobulin G. Selank extends that sequence with a tripeptide addition, a modification strategy commonly applied to short peptides to alter their stability profile during handling and analysis.
It is not a licensed medicine in the United Kingdom and holds no marketing authorisation. It is not a controlled substance under the Misuse of Drugs Act 1971.
For structural detail, published literature and citations, see the compound reference entry: /compounds/selank-10mg/
There are no reviews yet.